Fully two years into the COVID-19 pandemic, biopharmaceutical companies and academic/non-profit research organizations continue to partner on efforts to prevent and combat infections by the SARS-CoV-2 virus. But while the pandemic remains ongoing, a coalition of translational research bodies is using learnings from the COVID-19 experience to propose actions to help with the next pandemic.
Translation Together, an alliance comprising seven translational research organizations across North America, South America, the UK, European Union and Asia-Pacific, published an article on 28 January in Nature Reviews/Drug Discovery...